Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex

OBJECTIVE: The objective of this systematic review with meta-analysis was to evaluate the efficacy, safety, and short- and long-term tolerability of cannabidiol (CBD), as an adjunct treatment, in children and adults with Dravet syndrome (SD), Lennox-Gataut syndrome (LGS), or tuberous sclerosis compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvinato, Antônio, Floriano, Idevaldo, Bernardo, Wanderley Marques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2022
Materias:
Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683917/
https://www.ncbi.nlm.nih.gov/pubmed/36417631
http://dx.doi.org/10.1590/1806-9282.2022D689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683917/
https://www.ncbi.nlm.nih.gov/pubmed/36417631
http://dx.doi.org/10.1590/1806-9282.2022D689

Ejemplares similares